Literature DB >> 26224000

Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates.

Vivian Tien1, Elizabeth Robilotti1, Devin Callister1, Aruna Subramanian1, Glen Lutchman2, Dora Y Ho1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26224000      PMCID： PMC6276962          DOI： 10.1093/cid/civ639

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial.

Authors:  Julian Torre-Cisneros; Rafael San-Juan; Clara M Rosso-Fernández; J Tiago Silva; Agustin Muñoz-Sanz; Patricia Muñoz; Enrique Miguez; Pilar Martín-Dávila; Miguel Angel López-Ruz; Elisa Vidal; Elisa Cordero; Miguel Montejo; Marino Blanes; M Carmen Fariñas; Jose Ignacio Herrero; Juan Rodrigo; Jose Maria Aguado
Journal:  Clin Infect Dis       Date:  2015-02-25       Impact factor: 9.079

Review 2.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 3.  Antimicrobial safety: focus on fluoroquinolones.

Authors:  Robert C Owens; Paul G Ambrose
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.